Gene: ZBTB43
Official Full Name: zinc finger and BTB domain containing 43provided by HGNC
Gene Summary: Enables RNA polymerase III general transcription initiation factor binding activity and sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29861 | ZBTB43 Knockout cell line (HeLa) | Human | ZBTB43 | 1:3~1:6 | Negative | Online Inquiry |
KO29862 | ZBTB43 Knockout cell line (HCT 116) | Human | ZBTB43 | 1:2~1:4 | Negative | Online Inquiry |
KO29863 | ZBTB43 Knockout cell line (HEK293) | Human | ZBTB43 | 1:3~1:6 | Negative | Online Inquiry |
KO29864 | ZBTB43 Knockout cell line (A549) | Human | ZBTB43 | 1:3~1:4 | Negative | Online Inquiry |
ZBTB43 Gene Knockout Cell Lines are specialized cellular models that have been engineered to eliminate the expression of the ZBTB43 gene, which encodes for a zinc finger transcription factor involved in various cellular processes, including proliferation, differentiation, and apoptosis. By disrupting this gene, researchers can mimic conditions relevant to specific diseases, explore gene function, and validate potential therapeutic targets, thereby deepening our understanding of the underlying mechanisms of disease.
The primary mechanism operating within these knockout cell lines involves the CRISPR-Cas9 genome-editing technology, which ensures precise and efficient knockout of the target gene. This genetic modification allows for the observation of phenotypic changes that occur in the absence of ZBTB43, such as alterations in cell cycle regulation and response to stimuli. Such insights are invaluable for studying the gene's role in cancer biology, autoimmune disorders, and other diseases where transcriptional regulation is disrupted.
From a scientific standpoint, ZBTB43 Gene Knockout Cell Lines serve as essential tools in drug discovery, biomarker validation, and functional genomics. Their applications extend to high-throughput screening for novel compounds that can modulate ZBTB43-related pathways, ultimately offering avenues for developing targeted therapies.
Compared to traditional cell lines where the gene is still expressed, these knockout models offer a clearer picture of the gene's role, which facilitates the exploration of precise mechanisms without confounding variables. Additionally, the availability of these specialized lines can significantly expedite research timelines and enhance reproducibility in experimental outcomes, making them a superior choice for many laboratories.
Researchers and clinicians looking to investigate the intricate relations between ZBTB43 and disease will find immense value in utilizing these knockout cell lines. Our company has extensive expertise in gene editing and cellular biology, ensuring that we deliver high-quality, reliable products designed to advance scientific inquiry and therapeutic development. This commitment to excellence in biological research underpins our offerings, providing customers with the confidence they need to explore complex biological questions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.